HLA-G and neoplasm: Recognizing the presence and collaboration of multiple ICPs and the challenges posed by adaptive resistance when solely targeting the PD‐1/PD‐L1 pathway,[7a,b] we developed Nb‐TriTE with a novel construct containing VHH fragments directed toward PD‐L1 and HLA‐G on tumor cells.